The Lancet CAH Commission on the Future of Neonatology—launched in 2022 under Hon. Commissioner Kyriakides—has just released its landmark position paper in The Lancet Child & Adolescent Health. Presented by Prof. Mark Turner in Nijmegen and Prof. Daniele De Luca in Alicante, the report brings together insights from nearly 100 global experts.
With a clear message—“We do not want to treat babies in 20 years like we did 20 years ago”—the Commission calls for urgent action to address the lack of neonatal-specific medicines, devices, training, and recognition. It highlights major barriers caused by adult-focused regulations and outlines key recommendations for regulators, industry, academia, clinicians, and patient representatives.
From the 24th to the 27th of June 2025 the historic city of Nijmegen welcomed participants to the biannual ESDPPP Conference 2025, and it was an outstanding success! Led by the ESDPPP President Prof. Saskia de Wildt, the event brought together 150 participants from more than 17 countries, uniting experts and emerging voices from across the globe.
The scientific program was both rich and dynamic, covering a broad range of cutting-edge topics including innovative dose finding, study design innovations, off-label medication use, pre-clinical drug discovery, and much more. Sessions sparked engaging discussion, fostered collaboration, and reflected the growing impact of our international community.
The social program provided the perfect balance—offering space for informal exchange, new connections, and memorable moments against the charming backdrop of Nijmegen.
A heartfelt thank you to all who contributed to making this year’s conference such a meaningful experience—from speakers and organizers to each and every participant.
We are already looking ahead with great anticipation to the next ESDPPP Conference, which will take place in Berchtesgaden, Germany in 2027, under the leadership of Conference President Prof. Antje Neubert. We look forward to welcoming you there!
Join us on December 5th, 5:00–6:00 pm CEST for an essential ESDPPP webinar on drug safety,
with a focus on paediatric pharmacovigilance and risk management.
We’re pleased to welcome Prof. Antje Neubert (University Hospital Erlangen, Germany) and Dr. Beate Aurich (Consultant at SASU, Paris, France) as our expert speakers.
The registration is free for all paying members. Non-members are welcome to join with a small contribution towards costs (20 EUR). Sign up via email to reserve your spot (secretarygenesdppp@gmail.com or anna.wiesinger@pmu.ac.at)
Don’t miss this opportunity to deepen your understanding of paediatric drug safety practices!
We are thrilled to announce that the abstracts from the Prague Conference 2023, curated by our esteemed society president Pavla Pokorna, have been published in BMJ Paediatrics Open. This prestigious publication highlights the groundbreaking research and innovative developments presented at the conference. We invite you to explore these abstracts to stay at the forefront of pediatric science and healthcare advancements.
It is with heavy hearts that we announce the passing of Prof. Dr. Anders Rane, a distinguished member and former president of our society and a luminary in the field of developmental pharmacology. Prof. Dr. Rane passed away on May 2nd, 2024. Prof. Dr. Rane was a trailblazer in the realm of clinical pharmacology, leaving an indelible mark on the scientific community through his groundbreaking research and exemplary leadership. Born on July 4th, 1943 in Bromma (Sweden), Prof. Dr. Rane embarked on a remarkable journey that would shape the landscape of pediatric and perinatal pharmacology for generations to come. His contributions to developmental pharmacology are immeasurable, and his spirit will continue to guide us in our pursuit of excellence and innovation.
On behalf of the society, we extend our deepest condolences.
May his memory be a source of comfort and inspiration to us all.
Based in Ghent, Belgium, ESDPPP promotes research in developmental perinatal and paediatric pharmacology and offers a forum for dialogue between pharmacologists, clinicians, and scientists interested in the effect of medicines on the developing fetus, infant, and child.
The ESDPPP celebrated its 37th anniversary in 2025. This milestone provides an important opportunity to celebrate ESDPPP’s achievements to date and to describe our future aspirations and ambitions on behalf of millions of paediatric patients worldwide.
We aim to improve medicines for children and advance research and global access to paediatric medicines. We also advocate politically for the continued development of safe, evidence-based medications for children. In this respect, ESDPPP works closely with European Medicines Agency (EMA), International Union of Basic and Clinical Pharmacology (IUPHAR) and the World Health Organization (WHO).
Meeting our colleagues is very important for our society. We enjoyed a wonderful congress in Nijmegen, NL, this year and are already looking forward to our next congress, which will be held in Germany 2027. We highly welcome your idea and suggestion for this event.
Join us on LinkedIn!!
We want to use LinkedIn for announcements and discussions in our field. Please check out our group page on LinkedIn and become a group member.
The official journal of the ESDPPP is the leading paediatric journal Archives of Disease in Childhood. It contains a Drug Therapy section which is published every 3 months.
ESDPPP is associated with a range of organizations like EMEA, IUHAR and WHO. Additional information on projects, initiatives and conferences will be available within short.
This year ESDPPP celebrates its 37th anniversary at the society's 21st conference in Nijmegen, The Netherlands. The meeting will be hosted by our president Saskia de Wildt.
After the congress ...
Our last congress in Nijmegen was a great success and a meeting place for many. Did you enjoy it as well? Become a member of ESDPPP and be the first to know more about the next congress in the Berchtesgaden.
Contact information
ESDPPP VZW p/a University Hospital
Gasthuisberg Herestraat 49
B-3000 Leuven